Stay updated on Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.

Latest updates to the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAn NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The clinical trial record remains inaccessible behind a 403 error.SummaryDifference1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe 403 error page footer now shows revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check37 days agoChange DetectedThe study page now presents a 403 Forbidden error with a minimal header where the study details would normally appear.SummaryDifference24%

- Check44 days agoChange DetectedRevision: v3.7.0 was added, replacing the previous Revision: v3.6.6 and signaling an update to the page's revision history.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page history now shows Revision: v3.6.6 as the latest update and removes Revision: v3.6.5.SummaryDifference0.0%

- Check80 days agoChange DetectedA new revision tag (v3.6.5) was added, indicating a platform update without altering the study information.SummaryDifference0.0%

Stay in the know with updates to Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.